Home | UK Clinical Vaccine Network Conference

UK Clinical Vaccine Network Conference
Wednesday 12th - Thursday 13th June 2024

Registration

Registration for 2025 will open soon.
Register for the UK Clinical Vaccine Network Conference 2024 below.

For any queries regarding registration, please contact Andy Cockayne.

£100

Standard Delegate

Physical and Online access to the conference

£60

Student/ Trainee

Physical and Online access to the conference

£60

Virtual

Online access to the conference

£300

Commercial

Physical and Online access to the conference

£90

2024 - On Demand

Selected 2024 Recordings

Cutlers' Hall

7-15 Church St, Sheffield City Centre, Sheffield S1 1HG

Last Year's Agenda

DAY 1
12:15 Lunch & Networking
SESSION 1: Behavioural Change & Vaccine Uptake
Chair: Rajeka Lazarus
13:05
Opportunities to support vaccination in migrant populations
Sally Hargreaves
13:20
Increasing vaccine uptake in underserved groups: systematic review findings
Clare French
13:35
Influenza vaccination in alternative settings: Improving uptake among the under 65s at risk
Benjamin Kasstan
13:50
Q&A
SESSION 2: Next generation vaccine deployment in LMICs
Chair: Christopher Green
14:05
Rwanda's Experiences in Building Research Capacity and Deploying Vaccines
Claude Muvunyi
14:25
Vaccine clinical research in subsaharan africa: the experience of Rwanda
Julien Nyombire
14:45
Developing vaccines against invasive non typhoidal Salmonella disease
Maheshi Ramasamy
15:05
Q&A
15:15 Refreshment Break
SESSION 3: Sponsored session - GSK
Chair: Saul Faust
15:35
Vaccination Landscape in the UK
Catherine Heffernan
SESSION 4: Keynote - Update on the Vaccine Innovation Pathway
Chair: Rebecca Sutherland
16:10
UK Vaccine Innovation Pathway
Saul Faust
SESSION 5: The Great Vaccine Debate - "The RNA vaccine revolution; is it the future?"
Chair: Christopher Green
16:35
Panel Discussion
Chris Green, Saul Faust and Adam Cunningham
17:15
Day 1 Close

DAY 2
Welcome and Opening Remarks
Chair: Christopher Green
SESSION 6: Vaccines for immune deficiency patients
Chair: Rajeka Lazarus
08:40
Primary immune deficiencies
Alex Richter
09:00
Secondary immune deficiencies
Paul Moss
09:20
Q&A
SESSION 7: Global Health Vaccines Part 1
Chair: Rebecca Sutherland
09:35
Road to a next-generation high-efficacy vaccine for P. falciparum malaria
Angela Minassian
09:55
Vaccine development against the plague and implications for novel bacterial vaccines
Christine Rollier
10:15
Q&A
10:20 Refreshment Break & Poster Viewing
SESSION 8: Abstracts
Chair: Katrina Pollock
10:50
Vaccines to prevent antimicrobial resistance – data from a phase 3 typhoid conjugate vaccine trial in Blantyre, Malawi
James Meiring
11:00
Determinants of maternal vaccination inequity in England: the maternity staff perspective
Emma Anderson
11:10
The Forgotten Facet of Immunological Memory: CD8+ T cell Epitope Prediction of Gonococcal Antigens
Made Krisna
SESSION 9: Global Health Vaccines Part 2
Chair: Tom Darton
11:25
Design and proof of principle in a mouse model of a promising vaccine for Zika virus currently in Phase I clinical trial
Thomas Blanchard
11:45
T-cell responses in dengue virus infection and implications for vaccine design
Laura Rivino
12:05
Q&A
12:15 Lunch & Poster Viewing
SESSION 10: Sponsored Session - Pfizer
13:00
COVID-19 Variants and Updated Vaccines
Juleen Gayed
SESSION 11: "Ageing well; vaccines for older people"
Chair: Ruth Payne
13:25
Human Infection Challenge: Respiratory viruses pneumococcus co-infections and implications for vaccination
Daniela Ferreira
13:45
Understanding immunity against respiratory viruses in older people by controlled human infection
Chris Chiu
14:05
Lung Cancer Vaccines
Gary Middleton
14:25
Q&A
14:35 Refreshment break & poster viewing
SESSION 12: "Beyond HIV, vaccines for sexual health"
14:55
Developing a vaccine strategy for gonococcal vaccines
Peter Davis
15:10
Chlamydia Vaccines
Katrina Pollock
15:25
Mpox immunology... what we learned and what it means for the future
Ashley Otter
15:40
Panel Discussion
16:00
Closing Remarks and Poster Prize Presentation
Christopher Green
16:30
Conference Close

Abstract Submission

Abstract submission for 2025 are will open soon!

Our 2024 Poster Winner

Sian Faustini
Time of day of vaccination does not influence antibody responses to pneumococcal and annual influenza vaccination in a cohort of healthy older adults.

Our 2023 Poster Winner

Dr Ioannis Baltas
Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals.

Sponsors

We have a variety of sponsor packages available for the UK Clinical Vaccine Network Conference 2025. To find out more or to book a package, please contact Kirsty at kirstyf@pagemedical.co.uk.

Top